FUROSCIX: payments to doctors
Payments that named FUROSCIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.9M
- Providers
- 16,102
- Transactions
- 39,539
- Average per transaction
- $73
The per-transaction average — $73 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 16,102 providers the average total is $179, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Scpharmaceuticals Inc. | $2,889,861 | 100.0% |
| Shorla Oncology Inc. | $270 | 0.0% |